Literature DB >> 22738608

Optic nerve head, retinal nerve fiber layer, and macular thickness measurements in young patients with retinitis pigmentosa.

Young Hoon Hwang1, Seong-Woo Kim, Yong Yeon Kim, Jung Hwa Na, Hwang Ki Kim, Yong Ho Sohn.   

Abstract

PURPOSE: To evaluate optic nerve head (ONH) parameters, peripapillary retinal nerve fiber layer (RNFL) thickness, and macular thickness by using Cirrus HD spectral-domain optical coherence tomography (OCT) in young patients with retinitis pigmentosa (RP).
METHODS: ONH parameters, RNFL thickness, and macular thickness were measured and compared between 36 eyes from 36 young RP patients (RP group; mean age, 23.08 years) and 70 eyes from 70 healthy young subjects (control group; mean age, 22.66 years) using Cirrus HD-OCT. The effects of the presence of optic disc pallor and the severity of visual field (VF) defects on OCT parameters were also evaluated.
RESULTS: The RP group had a greater rim area, smaller cup-to-disc ratio, smaller cup volume, thicker RNFL, and thinner macula than the control group (p ≤ 0.024). ONH parameters were not affected by the presence of optic disc pallor (p ≥ 0.239). Eyes with more severe VF defects (mean deviation ≤ -13.88 dB) had thinner average macular areas than eyes with less severe VF defects (mean deviation ≥ -13.88 dB; p = 0.002). Meanwhile, the ONH parameters and average peripapillary RNFL thickness were not significantly different between the two groups (p ≥ 0.275).
CONCLUSIONS: Young eyes with RP exhibited different OCT parameters compared to healthy eyes. Among the various OCT parameters, only macular thickness was associated with disease severity. These findings should be considered when evaluating young RP patients.

Entities:  

Mesh:

Year:  2012        PMID: 22738608     DOI: 10.3109/02713683.2012.688163

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  8 in total

1.  Spectral-domain optical coherence tomography reveals prelaminar membranes in optic nerve head pallor in eyes with retinitis pigmentosa.

Authors:  Saba Al Rashaed; Arif O Khan; Sawsan R Nowilaty; Deepak P Edward; Igor Kozak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-22       Impact factor: 3.117

2.  Longitudinal analysis of the peripapillary retinal nerve fiber layer thinning in patients with retinitis pigmentosa.

Authors:  A Oishi; K Ogino; S Nakagawa; Y Makiyama; M Kurimoto; A Otani; N Yoshimura
Journal:  Eye (Lond)       Date:  2013-03-22       Impact factor: 3.775

Review 3.  Retinitis Pigmentosa: Progress in Molecular Pathology and Biotherapeutical Strategies.

Authors:  Wanqin Liu; Shanshan Liu; Ping Li; Kai Yao
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

4.  Severe retinal degeneration in women with a c.2543del mutation in ORF15 of the RPGR gene.

Authors:  Bohdan Kousal; Pavlina Skalicka; Lucie Valesova; Tracy Fletcher; Niki Hart-Holden; Anna O'Grady; Christina F Chakarova; Michel Michaelides; Alison J Hardcastle; Petra Liskova
Journal:  Mol Vis       Date:  2014-09-20       Impact factor: 2.367

5.  Glial proliferation and atrophy: Two poles of optic disc in patients with retinitis pigmentosa.

Authors:  Cagri Ilhan; Mehmet Citirik
Journal:  J Curr Ophthalmol       Date:  2019-08-30

6.  Reduced macular function in ABCA4 carriers.

Authors:  Ulrika Kjellström
Journal:  Mol Vis       Date:  2015-07-17       Impact factor: 2.367

7.  The Structure-Function Relationship between Macular Morphology and Visual Function Analyzed by Optical Coherence Tomography in Retinitis Pigmentosa.

Authors:  Chang Ki Yoon; Hyeong Gon Yu
Journal:  J Ophthalmol       Date:  2013-12-03       Impact factor: 1.909

8.  Analysis of imaging biomarkers and retinal nerve fiber layer thickness in RPGR-associated retinitis pigmentosa.

Authors:  Theresa H Birtel; Johannes Birtel; Kristina Hess; Amelie C Clemens; Moritz Lindner; Philipp Herrmann; Frank G Holz; Martin Gliem
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-07-21       Impact factor: 3.117

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.